EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 299 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $691 | +659.3% | 101,458 | +278.8% | 0.00% | – |
| Q3 2023 | $91 | +62.5% | 26,782 | +459.9% | 0.00% | – |
| Q4 2022 | $56 | -99.9% | 4,783 | +168.4% | 0.00% | – |
| Q2 2022 | $55,000 | -24.7% | 1,782 | 0.0% | 0.00% | – |
| Q1 2022 | $73,000 | +15.9% | 1,782 | +41.3% | 0.00% | – |
| Q3 2021 | $63,000 | -32.3% | 1,261 | -15.5% | 0.00% | – |
| Q2 2021 | $93,000 | -99.7% | 1,492 | -99.6% | 0.00% | -100.0% |
| Q1 2021 | $34,482,000 | +10.2% | 371,138 | +6.2% | 0.04% | +5.0% |
| Q4 2020 | $31,299,000 | -9.3% | 349,324 | +4.6% | 0.04% | -18.4% |
| Q3 2020 | $34,524,000 | +32.8% | 334,118 | +1.6% | 0.05% | +22.5% |
| Q2 2020 | $26,004,000 | +19.9% | 328,835 | -12.3% | 0.04% | 0.0% |
| Q1 2020 | $21,684,000 | -25.4% | 374,770 | -30.5% | 0.04% | -4.8% |
| Q4 2019 | $29,082,000 | -6.7% | 539,055 | -9.6% | 0.04% | -17.6% |
| Q3 2019 | $31,169,000 | -10.3% | 596,195 | -17.2% | 0.05% | -8.9% |
| Q2 2019 | $34,765,000 | – | 719,630 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |